Proteocyte AI announced they have signed a partnership agreement to integrate Proscia’s technology with Straticyte™, a specific test for predicting the risk of progression to oral cancer. Proteocyte AI will leverage Proscia’s cloud-based platform to orchestrate workflows of patients, doctors, and laboratories, enabling Proteocyte AI to offer a more comprehensive solution.
Proteocyte AI Announces Partnership With Proscia Digital
Previous
Previous
OBIO Launches 'Use It or Lose It', Latest Report on the Future of Canada’s Health Science Industry
Next
Next